close
On the Record
6 mins to read

The real cost of not funding life-saving or enhancing drugs

OPINION: Uncovered: under-treatment, healthcare inequity, needless suffering, untimely death.

You may have come across Murray Denyer.

He’s been around the traps a bit over the years, fighting to remove trade barriers or improve market access for some of our big exporters of kiwifruit and apples.

He worked for MFAT in the 1990s as a young diplomat. It was a dream job based

Want to read more? It's easy.

Choose your best value subscription option

Student

NZ uni students have FREE access (valued at $499) to NBR in 2024.
Individual
Group membership
NBR Marketplace
NZ Aviation News

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Aviation News - Monthly

NZ$14.95 / monthly

Already have an account? Login
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
The real cost of not funding life-saving or enhancing drugs
On the Record,Columns,
89710